Odronextamab
Monoclonal antibody / From Wikipedia, the free encyclopedia
Odronextamab (REGN1979) is a CD20 x CD3 bispecific monoclonal antibody that is developed by Regeneron Pharmaceuticals for B-cell non-Hodgkin lymphoma.[1][2][3][4]
Quick Facts Monoclonal antibody, Type ...
Monoclonal antibody | |
---|---|
Type | Bi-specific T-cell engager |
Source | Humanized |
Target | CD20, CD3 |
Clinical data | |
Other names | REGN1979; REGN-1979 |
Drug class | Antineoplastic |
ATC code |
|
Identifiers | |
CAS Number | |
UNII |
Close